Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model

Launched by UNIVERSITY HOSPITAL, LINKOEPING · Mar 18, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how to improve cancer treatment for patients with colorectal cancer that has spread to the liver. Researchers are using zebrafish embryos as a model to see how tumors grow and respond to different chemotherapy treatments. The goal is to find faster and more effective ways to determine which treatments will work best for individual patients, rather than relying on trial and error.

To participate in this trial, you need to be at least 18 years old and have a confirmed or suspected diagnosis of colorectal liver metastasis. You should also be able to understand the information provided about the study. If you join, your tumor tissue will be tested with zebrafish to see how it reacts to various chemotherapy combinations. This could lead to more personalized and effective treatment options in the future. The trial is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed or suspected diagnosis of colorectal liver metastasis Age 18 years or older ECOG 0-2 Patient can understand verbal and written information -
• Exclusion Criteria:
• • Age less than 18 years ECOG \>2 Patient is not able to understand the verbal and written information
• • -